Advertisement

Neurofibrillary pathology in progressive supranuclear palsy (PSP)

  • J. Cervós-Navarro
  • K. Schumacher
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 42)

Summary

In progressive supranuclear palsy (PSP), globose neurofibrillary tangles (NFT) are found in the subcortical areas and occasionally in the central cortex and spinal cord. An inverse relationship was found between the degree of neuronal loss and the presence of NFT.

It has been postulated that NFT comes first and atrophy as a secondary event. Others authors have reported that the neurologic findings are associated with the presence of carcinomas and the CNS changes can be assessed as a paraneoplastic effect. In PSP the neuritic changes are mainly located in the basal ganglia and composed of straight filaments and tubules, different from the paired helical filaments found in the Alzheimer’s disease, suggesting that they are formed of a new type of fibrous protein. In addition immunohistochemistry preparations using antibodies against tau and ubiquitin reveal an antigenic profile similar to early NFT in dementia of Alzheimer’s type. These findings support the hypothesis that these changes may reflect different types of non-specific cytoskeletal disorganization.

Keywords

Progressive Supranuclear Palsy Neurofibrillary Tangle Progressive Supranuclear Palsy Paired Helical Filament Inferior Olivary Nucleus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe H, Yagishita S, Amano N, Bise K (1992) Ultrastructural and immunohistochemical study of “astrocytic tangles” (ACT) in patients with progressive supranuclear palsy. Clin Neuropathol 11: 278.Google Scholar
  2. Amano N, Iwabuchi K, Yokoi S, Yagishita S, Itoh J, Saitoh A, Nagatomo H, Matsushita M (1989) The reappraisal study of the ultrastructure of Alzheimer’s neurofibrillary tangles in three cases of progressive supranuclear palsy. No To Shinkei Brain and Nerve 41: 35–44.PubMedGoogle Scholar
  3. Anzil AP (1969) Progressive supranuclear palsy. Case report with pathological findings. Acta Neuropathol (Berl) 14: 72–76.CrossRefGoogle Scholar
  4. Arima K, Murayama S, Oyanagi S, Akashi T, Inose T (1992a) Presenile dementia with progressive supranuclear palsy tangles and Pick bodies: an unusual degenerative disorder involving the cerebral cortex, cerebral nuclei, and brain stem nuclei. Acta Neuropathol (Berl) 84: 128–134.CrossRefGoogle Scholar
  5. Arima K, Oyanagi S, Akashi T, Sakata C, Sunohara N, Inose T (1992b) Neurofibrillary tangles of progressive supranuclear palsy in the dentate fascia: an ultrastructural study of a case. Neuropathology 12: 51–57.Google Scholar
  6. Bancher C, Lassmann H, Budka H, Grundke-Iqbal I, Iqbal K, Wiche G, Scitelberger F, Wisniewski HM (1987) Neurofibrillary tangles in Alzheimer’s disease and progressive supranuclear palsy: antigenetic similarities and differences. Acta Neuropathol (Berl) 74: 39–46.CrossRefGoogle Scholar
  7. Braak H, Braak E, Iqbal IG, Iqbal K (1986) Occurrence of neuropil threads in the senile human brain and in Alzheimer’s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65: 351–355.PubMedCrossRefGoogle Scholar
  8. Bugiani O, Macardi GL, Brusa A, Ederli A (1979) The fine structure of subcortical neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropathol (Berl) 45: 147–152.CrossRefGoogle Scholar
  9. Burger PC, Vogel FS (1973) The development of the pathologic changes of Alzheimer’s dementia and senile dementia in patients with Down’s syndrome. Am J Pathol 73: 457–476.PubMedGoogle Scholar
  10. Cammarata S, Mancardi G, Tabaton M (1990) Formic acid treatment exposes hidden neurofilament and tau epitopes in abnormal cytoskeletal filaments from patients with progressive supranuclear palsy and Alzheimer’s disease. Neurosci Lett 115: 351–355.PubMedCrossRefGoogle Scholar
  11. Dubas F, De Recondo J (1983) Paralysie supra-nucléaire progressive. Maladie de Steele, Richardson, Olszewski. Encyc Méd Chir(Paris) Neurologie, 17062 B-10.Google Scholar
  12. Flament S, Delacourte A, Verny M, Hauw JJ, Javoy-Agid F (1991) Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol 81: 591–596.PubMedCrossRefGoogle Scholar
  13. Galloway PG (1988) Antigenic characteristics of neurofibrillary tangles in progressive supranuclear palsy. Neurosci Lett 91: 148–153.PubMedCrossRefGoogle Scholar
  14. Ghatak NR, Nochlin D, Hadfield MG (1980) Neurofibrillary pathology in progressive supranuclear palsy. Acta Neuropathol (Berl) 52: 73–76.CrossRefGoogle Scholar
  15. Gheuens J, Cras P, Perry G, Boons J, Ceuterickdegroote C, Lubke U, Mercken M, Tabaton M, Gambetti PL, Vandermeeren M, Mulvihill P, Siedlak S, Vanheuverswijn H, Martin JJ (1991) Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases. Brain Res 558/N1: 43–52.CrossRefGoogle Scholar
  16. Harada AK, Krucke GL, Mancardi TI (1986) Alzheimer’s tangles in sudanophilic leucodystrophy. J Neuropathol Exp Neurol 45: 349.CrossRefGoogle Scholar
  17. Hauw JJ, Verny M, Delaere P, Cervera P, He Y, Duyckaerts C (1990) Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer’s disease and aging. Neurosci Lett 119: 182–186.PubMedCrossRefGoogle Scholar
  18. Hirano A (1970) Neurofibrillary changes in conditions related to Alzheimer’s disease. In: Wolstenholme GEW, O’Connor (eds) Alzheimer’s disease and related conditions. Ciba Foundation Symposium. Churchill, London, pp 185–207.Google Scholar
  19. Hirano A, Malamud N, Kurland LT (1961) Parkinsonism-dementia complex, an endemic disease in the island of Guam. II. Pathological features. Brain 84: 662–679.PubMedCrossRefGoogle Scholar
  20. Hof PR, Delacourte A, Bouras C (1992) Distribution of cortical neurofibrillary quantitative analysis of six cases. Acta Neuropathol (Berl) 84: 45–51.PubMedCrossRefGoogle Scholar
  21. Hunter S (1985) The rostral mesencephalon in Parkinson’s disease and Alzheimer’s disease. Acta Neuropathol (Berl) 68: 53–58.CrossRefGoogle Scholar
  22. Ishino H, Otsuki S (1976) Frequency of Alzheimer’s neurofibrillary tangles in the cerebral cortex in progressive supranuclear palsy (subcortical argyrophilic dystrophy). J Neurol Sci 28: 306–316.CrossRefGoogle Scholar
  23. Ishino H, Sasaki T, Yamashita K, Seno H, Kodaka H, Yoshinaga J, Ideshita H, Yamanaka T, Hikiji A (1987) A case of progressive supranuclear palsy with fibrillary gliosis of the midbrain and pontine reticular formation. Clin Neuropathol 6: 61–66.PubMedGoogle Scholar
  24. Jankovic J (1985) Progressive supranuclear palsy: paraneoplastic effect of bronchial carcinoma. Neurology 35: 446–447.PubMedCrossRefGoogle Scholar
  25. Jellinger K, Riederer R, Tomonaga M (1980) Progressive supranuclear palsy. Clinical, pathological and biochemical studies. J Neural Transm [Suppl] 16: 111–128.Google Scholar
  26. Kalaria RN, Galloway PG, Perry G (1991) Widespread serum amyloid P immunoreac-tivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer’s disease and degenerative disorders. Neuropathol Appl Neurobiol 17: 189–201.PubMedCrossRefGoogle Scholar
  27. Kato T, Hirano A, Jacobs AK, Weinberg AK, Weinberg MN (1986) Spinal cord lesions in progressive supranuclear palsy: some new observations. J Neuropathol Exp Neurol 45: 377.CrossRefGoogle Scholar
  28. Kleinschmidt-DeMasters BK (1989) Early progressive supranuclear palsy: pathology and clinical presentation. Clin Neuropathol 8: 79–84.PubMedGoogle Scholar
  29. Kristensen MO (1985) Progressive supranuclear palsy — 20 years later. Acta Neurol Scand 71: 177–189.PubMedCrossRefGoogle Scholar
  30. Masliah E, Hansen LA, Quijada S, et al (1991) Late-onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy. Ann Neurol 29: 389–396.PubMedCrossRefGoogle Scholar
  31. Meyers K, Dorenkamp DG, Suzuki K (1974) Amyotrophic lateral sclerosis with diffuse neurofibrillary changes. Arch Neurol (Chic) 30: 84–89.CrossRefGoogle Scholar
  32. Nelson SJ, Yen SH, Davies P, Dickson DW (1989) Basal ganglia neuropil threads in progressive supranuclear palsy. J Neuropathol Exp Neurol 48: 324.CrossRefGoogle Scholar
  33. Ohara PT (1972) Electron microscopical study of the brain in Down’s syndrome. Brain 95: 681–684.PubMedCrossRefGoogle Scholar
  34. Olson MI, Shaw C-M (1969) Presenile dementia and Alzheimer’s disease in mongolism. Brain 92: 147–156.PubMedCrossRefGoogle Scholar
  35. Perry G, Richey P, Siedlak SL, Galloway P, Kawai M, Cras P (1992) Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases. Brain Res 579: 350–352.PubMedCrossRefGoogle Scholar
  36. Probst A, Langui D, Lautenschlager C, Ulrich J, Brion JP, Anderton BH (1988) Progressive supranuclear palsy: extensive neuropil threads in addition to neuro-fibrillary tangles. Acta Neuropathol (Berl) 77: 61–68.CrossRefGoogle Scholar
  37. Roy S, Datta CK, Hirano A, Ghatak NR, Zimmermann HM (1974) Electronmicroscopic study of neurofibrillary tangles in Steele-Richardson Olszewski syndrome. Acta Neuropathol (Berl) 29: 175–179.CrossRefGoogle Scholar
  38. Scitelberger F (1969) Heterogenous system degeneration. Subcortical argyrophilic dystrophy. Acta Neurol 24: 276–284.Google Scholar
  39. Shortridge BA, Vogel FS, Burger PC (1985) Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brainstem of patients with senile dementia of the Alzheimer’s type and Down’s syndrome. Clin Neuropathol 4: 227–237.PubMedGoogle Scholar
  40. Steele JC (1972) Progressive supranuclear palsy. Brain 95: 693–704.PubMedGoogle Scholar
  41. Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. Arch Neurol 10: 333–359.PubMedCrossRefGoogle Scholar
  42. Tabaton M, Schenone A, Romagnoli P, Mancardi GL (1985) A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer’s disease. Acta Neuropathol (Berl) 68: 218–223.CrossRefGoogle Scholar
  43. Tabaton M, Whitehouse PJ, Perry G, Davies P, Autilio-Gambetti L, Gambetti P (1988) Alz 50 recognizes abnormal filaments in Alzheimer’s disease and progressive supranuclear palsy. Ann Neurol 24: 407–413.PubMedCrossRefGoogle Scholar
  44. Takahashi H, Oyanagi K, Takeda S, Hinokuma K, Ikuta F (1989) Occurence of 15-nm-wide straight tubules in neocortical neurons in progressive supranuclear palsy. Acta Neuropathol (Berl) 79: 233–239.CrossRefGoogle Scholar
  45. Takauchi S, Mizuhara T, Miyoshi K (1983) Unusual paired helical filaments in progressive supranuclear palsy. Acta Neuropathol (Berl) 59: 225–228.CrossRefGoogle Scholar
  46. Téllez-Nagel I, Wisniewski HM (1973) Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol 29: 324–327.PubMedCrossRefGoogle Scholar
  47. Terry RD, Wisniewski HM (1970) The ultrastructure in the neurofibrillary tangles and the senile plaque. In: Wolstenholme GEW, O’Connor M (eds) Alzheimer’s disease and related conditions. Ciba Foundation Symposium. Churchill, London, pp 145–165.Google Scholar
  48. Tomonaga M (1977) Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropathol (Berl) 37: 177–181.CrossRefGoogle Scholar
  49. Wisniewski HM, Terry RD (1970) An experimental approach to the morphogenesis of neurofibrillary degeneration and the argyrophilic plaque. In: Wolstenholme GEW, O’Connor M (eds) Alzheimer’s disease and related conditions. Ciba Foundation Symposium. Churchill, London, pp 223–248.Google Scholar
  50. Wisniewski HM, Terry RD, Hirano A (1976) Neurofibrillary pathology. J Neuropathol Exp Neurol 29: 163–176.CrossRefGoogle Scholar
  51. Yamada T, McGeer PL, McGeer EG (1992) Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy in brain tissue. Neurosci Lett 135: 99–102.PubMedCrossRefGoogle Scholar
  52. Yamamoto T, Kawamura J, Hashimoto S, Nakamura M, Iwamoto H, Kobashi Y, Ichijima K (1992) Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: a case of akinesia as a predominant feature of parkinsonism. J Neurol Sci 101: 98–106.CrossRefGoogle Scholar
  53. Yen S-H, Horoupian DS, Terry RD (1983) Immunocytochemical comparison of neur-ofibrillary tangles in senile dementia of Alzheimer type, progressive supranuclear palsy, and postencephalitic Parkinsonism. Ann Neurol 13: 172–175.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1994

Authors and Affiliations

  • J. Cervós-Navarro
    • 1
  • K. Schumacher
    • 1
  1. 1.Institute of NeuropathologyFree University of BerlinBerlinFederal Republic of Germany

Personalised recommendations